Literature DB >> 32482954

Language Matters: It Is Time We Change How We Talk About Addiction and its Treatment.

Aleksandra E Zgierska1, Michael M Miller, David P Rabago, Florence Hilliard, Patty McCarthy, Penney Cowan, Edwin A Salsitz.   

Abstract

The way we communicate about addiction, its treatment, and treatment outcomes matters to individuals affected by addiction, their families, and communities. Stigmatizing language can worsen addiction-related stigma and outcomes. Although non-professional terminology may be used by individuals with addiction, the role of clinicians, educators, researchers, policymakers, and community and cultural leaders is to actively work toward destigmatization of addiction and its treatment, in part through the use of non-stigmatizing language. Role-modeling better approaches can help us move away from the inaccurate, outdated view of addiction as a character flaw or moral failing deserving of punishment, and toward that of a chronic disease requiring long-term treatment. Non-stigmatizing, non-judgmental, medically-based terminology and the adoption of person-first language can facilitate improved communication as well as patient access to and engagement with addiction care. Person-first language, which shifts away from defining a person through the lens of disease (eg, the term "a person with addiction" is recommended over the terms "addict" or "addicted patient"), implicitly acknowledges that a patient's life extends beyond a given disease. While such linguistic changes may seem subtle, they communicate that addiction, chronic pain and other diseases are only one aspect of a person's health and quality of life, and can promote therapeutic relationships, reduce stigma and health and disparities in addiction care. This article provides examples of stigmatizing terms to be avoided and recommended replacements to facilitate the dialogue about addiction in a more intentional, therapeutic manner.
Copyright © 2020 American Society of Addiction Medicine.

Entities:  

Mesh:

Year:  2021        PMID: 32482954      PMCID: PMC7704939          DOI: 10.1097/ADM.0000000000000674

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   4.647


  11 in total

1.  Recommended Use of Terminology in Addiction Medicine.

Authors:  Richard Saitz; Shannon C Miller; David A Fiellin; Richard N Rosenthal
Journal:  J Addict Med       Date:  2021 Jan-Feb 01       Impact factor: 3.702

2.  Stigma and the public health agenda for the opioid crisis in America.

Authors:  Patrick W Corrigan; Katherine Nieweglowski
Journal:  Int J Drug Policy       Date:  2018-07-06

Review 3.  Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review.

Authors:  Leonieke C van Boekel; Evelien P M Brouwers; Jaap van Weeghel; Henk F L Garretsen
Journal:  Drug Alcohol Depend       Date:  2013-03-13       Impact factor: 4.492

4.  Stigma as a fundamental cause of population health inequalities.

Authors:  Mark L Hatzenbuehler; Jo C Phelan; Bruce G Link
Journal:  Am J Public Health       Date:  2013-03-14       Impact factor: 9.308

Review 5.  Ambiguous identities of drugs and people: A scoping review of opioid-related stigma.

Authors:  Melissa D McCradden; Denitsa Vasileva; Ani Orchanian-Cheff; Daniel Z Buchman
Journal:  Int J Drug Policy       Date:  2019-10-28

Review 6.  On the self-stigma of mental illness: stages, disclosure, and strategies for change.

Authors:  Patrick W Corrigan; Deepa Rao
Journal:  Can J Psychiatry       Date:  2012-08       Impact factor: 4.356

Review 7.  Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders.

Authors:  R Hammarlund; K A Crapanzano; L Luce; L Mulligan; K M Ward
Journal:  Subst Abuse Rehabil       Date:  2018-11-23

8.  The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas.

Authors:  Anne L Stangl; Valerie A Earnshaw; Carmen H Logie; Wim van Brakel; Leickness C Simbayi; Iman Barré; John F Dovidio
Journal:  BMC Med       Date:  2019-02-15       Impact factor: 8.775

9.  Stigma as a fundamental hindrance to the United States opioid overdose crisis response.

Authors:  Alexander C Tsai; Mathew V Kiang; Michael L Barnett; Leo Beletsky; Katherine M Keyes; Emma E McGinty; Laramie R Smith; Steffanie A Strathdee; Sarah E Wakeman; Atheendar S Venkataramani
Journal:  PLoS Med       Date:  2019-11-26       Impact factor: 11.069

Review 10.  The association between perceived stigma and substance use disorder treatment outcomes: a review.

Authors:  Kathleen A Crapanzano; Rebecca Hammarlund; Bilal Ahmad; Natalie Hunsinger; Rumneet Kullar
Journal:  Subst Abuse Rehabil       Date:  2018-12-27
View more
  3 in total

1.  From Underground to Mainstream: Establishing a Medical Lexicon for Psychedelic Therapy.

Authors:  Andrew Beswerchij; Dominic Sisti
Journal:  Front Psychiatry       Date:  2022-06-17       Impact factor: 5.435

2.  A socioecological framework for engaging substance-using pregnant persons in longitudinal research: Multi-stakeholder perspectives.

Authors:  Ellen Goldstein; Kendra Nervik; Shelbey Hagen; Florence Hilliard; Alyssa Turnquist; Ludmila N Bakhireva; Ryan McDonald; Pilar N Ossorio; Jamie Lo; Aleksandra E Zgierska
Journal:  Neurotoxicol Teratol       Date:  2021-05-21       Impact factor: 4.071

3.  Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER).

Authors:  Saskia Antwerpes; Marie Costa; Marion Coste; Morgane Bureau; Gwenaelle Maradan; Christophe Cutarella; Jacques Leloutre; Olivier Riccobono-Soulier; Sophie Hedoire; Elodie Frot; Fabienne Vernier; Stéphanie Vassas-Goyard; Tangui Barré; Danielle Casanova; Patrizia Carrieri
Journal:  Harm Reduct J       Date:  2022-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.